PubRank

S O'Shea

Author PubWeight™ 57.00‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission. HIV Med 2001 2.33
2 Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis 1983 2.07
3 New mutations associated with resistance not detected following zidovudine monotherapy in pregnancy when used in accordance with British HIV Association guidelines. HIV Med 2008 1.99
4 Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) 1982 1.66
5 Rubella immunity by four different techniques: results of challenge studies. J Med Virol 1980 1.58
6 PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol 1995 1.47
7 bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proc Natl Acad Sci U S A 1995 1.40
8 Veterinary nursing examinations. Vet Rec 1994 1.38
9 Use of dried whole blood spots for quantification of HIV-1 RNA. AIDS 1999 1.33
10 British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med 2008 1.33
11 Persistence of specific IgM and low avidity specific IgG1 following primary rubella. J Virol Methods 1992 1.32
12 Persistence of rubella antibody 8-18 years after vaccination. Br Med J (Clin Res Ed) 1984 1.30
13 Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees. J Infect Dis 1985 1.18
14 Rubella vaccines. Lancet 1979 1.10
15 Persistence of rubella antibodies after vaccination: detection after experimental challenge. Rev Infect Dis 1985 1.08
16 Antiretroviral therapy for HIV-2 infected patients. J Infect 2001 1.04
17 Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. J Thromb Haemost 2009 1.04
18 Genotyping of B and non-B subtypes of human immunodeficiency virus type 1. J Clin Microbiol 2005 1.03
19 Rubella serology by solid-phase radioimmunoassay: its potential for screening programmes. Clin Exp Immunol 1978 1.03
20 Evidence for horizontal and not vertical transmission of human herpesvirus 8 in children born to human immunodeficiency virus-infected mothers. Pediatr Infect Dis J 1999 1.02
21 Use of PCR for prenatal and postnatal diagnosis of congenital rubella. J Clin Microbiol 1995 1.01
22 Transmission of RA27/3 rubella vaccine strain to products of conception. Lancet 1981 1.01
23 Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella: implications for diagnosis and immunopathology. J Med Virol 1993 0.98
24 Renal medullary carcinoma: sonographic, computed tomography, magnetic resonance and angiographic findings. Eur J Radiol 2000 0.98
25 The reliability of point-of-care prothrombin time testing. A comparison of CoaguChek S and XS INR measurements with hospital laboratory monitoring. Int J Lab Hematol 2008 0.97
26 Potential risk of cross-infection during peripheral-venous access by contamination of tourniquets. Lancet 2000 0.97
27 Laminin in lung development: effects of anti-laminin antibody in murine lung morphogenesis. Dev Biol 1990 0.97
28 How well do low levels of rubella antibody protect? Lancet 1981 0.96
29 Rubella vaccination: persistence of antibodies for 10-21 years. Lancet 1988 0.94
30 Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV. HIV Med 2005 0.93
31 Automated rubella antibody screening:a cautionary tale. J Med Microbiol 1999 0.93
32 An altered intron inhibits synthesis of the acetylcholine receptor alpha-subunit in the paralyzed zebrafish mutant nic1. Genetics 1998 0.92
33 Human herpesvirus 8: seroepidemiology among women and detection in the genital tract of seropositive women. J Infect Dis 1999 0.90
34 Laparoscopic reduction of an ileoileal intussusception and resection of an inverted Meckel's diverticulum in an adult. Surg Endosc 2003 0.89
35 Rubella virus strains show no major antigenic differences. Intervirology 1992 0.87
36 Virus-specific and autoreactive T cell lines isolated from cerebrospinal fluid of a patient with chronic rubella panencephalitis. J Neuroimmunol 1989 0.86
37 Prevalence of antiretroviral resistance in a South London cohort of treatment-naive HIV-1-infected patients. AIDS 2001 0.85
38 HIV-2 in pregnancy: to treat or not to treat? Int J STD AIDS 1998 0.83
39 Characterization of the three Arabidopsis thaliana RAD21 cohesins reveals differential responses to ionizing radiation. J Exp Bot 2006 0.83
40 Physical breaks in the placental trophoblastic surface: significance in vertical transmission of HIV. AIDS 1996 0.82
41 Utilization of HIV point-of-care testing clinics in general practice and genitourinary medicine services in south-east London. Int J STD AIDS 2009 0.82
42 Managing oral anticoagulation therapy: improving clinical outcomes. A review. J Clin Pharm Ther 2008 0.81
43 Bronchial smooth muscle hypoplasia in mouse embryonic lungs exposed to a laminin beta1 chain antisense oligonucleotide. Mech Dev 1999 0.81
44 HIV clearance in an infant? Nature 1995 0.80
45 Expression of glycine receptors in rat sensory neurons vs. HEK293 cells yields different functional properties. Neurosci Lett 2001 0.79
46 Therapeutic, prophylactic, and preresection applications of laparoscopic gastric and biliary bypass for patients with periampullary malignancy. Surg Endosc 2005 0.79
47 Induction of thrombospondin 1 by retinoic acid is important during differentiation of neuroblastoma cells. J Clin Invest 1992 0.79
48 Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland. Br J Dermatol 2012 0.78
49 Quantification of HIV-1 RNA in cervicovaginal secretions: an improved method of sample collection. AIDS 1997 0.78
50 Significance of placental damage in vertical transmission of human immunodeficiency virus. J Med Virol 1996 0.77
51 Clinical utility of genotypic resistance tests for HIV-1-infected patients with low-level virological failure. J Clin Microbiol 2010 0.75
52 Rapid viral diagnosis. BMJ 1990 0.75
53 Rubella virus and chronic joint disease: is there an association? J Clin Microbiol 1998 0.75
54 Zidovudine monotherapy in pregnancy: is it state of the art? HIV Med 2009 0.75
55 Diagnosing HIV infection in patients presenting with glandular fever-like illness in primary care: are we missing primary HIV infection? HIV Med 2012 0.75
56 Implementation of thromboprophylaxis guidelines. Ir Med J 2013 0.75
57 Pilot scheme for performance assessment of HIV-1 genotypic resistance testing in the UK. Commun Dis Public Health 2004 0.75
58 Rubella-immunity gap: Is intranasal vaccination the answer? Lancet 1979 0.75
59 Protracted behavioral effects of neonatal morphine-pellet implantation in male rats. Pharmacol Biochem Behav 1979 0.75
60 Doctor-patient introductions: getting it right. Ir J Med Sci 2011 0.75
61 Progeny of male rats addicted neonatally to morphine. Proc West Pharmacol Soc 1979 0.75
62 Undiagnosed symptomatic primary HIV infections in South London. J Infect 2001 0.75
63 Strategy for rubella vaccination. Lancet 1983 0.75
64 Complications following pancreatic transplantations: imaging features. Abdom Imaging 2011 0.75
65 Thromboprophylaxis in myeloma: what is happening outside of clinical trials? Ir Med J 2014 0.75